Premium
Hla type and survival in lung cancer
Author(s) -
Weiss Gary B.,
Nawrocki Lynn B.,
Daniels Jerry C.
Publication year - 1980
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19800701)46:1<38::aid-cncr2820460108>3.0.co;2-v
Subject(s) - medicine , lung cancer , human leukocyte antigen , cancer , oncology , lung , immunology , antigen
A significant positive association between antigens HLA Aw 19 and/or HLA B5 and a disease‐free survival time of one year for patients with lung cancer has been reported but not confirmed. We have HLA‐typed 20 white patients with non‐oat‐cell bronchogenic carcinoma who have survived at least a year from the time of diagnosis. Half these patients possessed these antigens ( P < 0.08). This highly suggests that the presence of these antigens is associated with prolonged survival time. Now may be the time for performing large scale clinical trials using these antigens as stratification factors. Cancer 46:38–40, 1980.